Fundz

Respira Therapeutics, Inc. reported raising $9.11 Million in an initial SEC Form D filing, from an offering of $9.41 Million

PRIVATEApr 26, 2017$9.1M of $9.4M raised

Amount Raised

$9.11 Million

$9.11 Million sold, per SEC Form D (first sale Apr 26, 2017)

Round Type

Venture

Palo AltoHealthcare

Quick answer

Respira Therapeutics raised $9.11 Million in a funding round, dated April 26, 2017. Respira Therapeutics is based in Palo Alto, California, United States.

How much did Respira Therapeutics raise?
Respira Therapeutics raised $9.11 Million in a funding round on April 26, 2017.
What does Respira Therapeutics do?
Respira Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing RT234, a novel inhalation therapy for pulmonary hypertension.
Where is Respira Therapeutics based and how big is it?
Respira Therapeutics is based in Palo Alto, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Respira Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • BLUE RIDGE DAY SURGERY CENTER L P raised $167K (Pre-Seed) on June 9, 2017.
  • Zenomics, Inc. raised $2.8M (Seed) on June 9, 2017.
  • Trice Medical, Inc. raised $19M on June 8, 2017.
  • Ralexar Therapeutics, Inc. raised $4.1M (Seed) on June 8, 2017.
  • SENTE INC raised $5M (Seed) on June 8, 2017.
  • DeliverCareRX, Inc. raised $1.2M (Seed) on June 8, 2017.

Who to call at Respira Therapeutics, and when

A new round usually means Respira Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Respira Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Respira Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Respira Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Respira Therapeutics

Location

5901 INDIAN SCHOOL RD NE #107

Palo Alto, California, United States

About

Respira Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing RT234, a novel inhalation therapy for pulmonary hypertension. The company aims to provide patients with an as-needed treatment option to manage their symptoms effectively. Respira focuses on innovative delivery methods that enhance drug efficacy for pulmonary disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Respira Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Respira Therapeutics's next move

See what Strategic adds

Respira Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.